A Pilot Study of Intranasal Lidocaine in Acute Management of Pediatric Migraine
A Pilot Study of Intranasal Lidocaine in Acute Management of Pediatric Migraine and Migraine-like Headache: A Randomized Controlled Trial
Sponsor: University of British Columbia
This PHASE1 trial investigates Migraine in Children and Posttraumatic Headache and is currently completed. University of British Columbia leads this study, which shows 8 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
May 2021 — Jul 2024 [monthly]
Completed PHASE1
Status: Recruiting → Completed
-
Jan 2021 — May 2021 [monthly]
Recruiting PHASE1
-
Aug 2020 — Jan 2021 [monthly]
Recruiting PHASE1
Phase: PHASE4 → PHASE1
▶ Show 3 earlier versions
-
Mar 2020 — Aug 2020 [monthly]
Recruiting PHASE4
-
Nov 2019 — Mar 2020 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Feb 2019 — Nov 2019 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of British Columbia
For direct contact, visit the study record on ClinicalTrials.gov .